- Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor
Song Liu et al, 2021, Journal of Medicinal Chemistry CrossRef - Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport
Friederike Kosyna et al, 2018, Cells CrossRef - Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
Antonella Lucia Marretta et al, 2021, Pharmaceutics CrossRef - Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
Marije F. W. Semmelink et al, 2021, International Journal of Molecular Sciences CrossRef - Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
Qianqian Shan et al, 2020, The Korean Journal of Physiology & Pharmacology CrossRef - Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data
Hai-Yong Ren et al, 2015, BioMed Research International CrossRef - Small Molecule Inhibitors of CRM1
Bibiana I. Ferreira et al, 2020, Frontiers in Pharmacology CrossRef - Therapeutic Targets for Bone and Soft-Tissue Sarcomas
Shinji Miwa et al, 2019, International Journal of Molecular Sciences CrossRef - Targeting XPO1-Dependent Nuclear Export in Cancer
Ekaterina Kim et al, 2022, Biochemistry (Moscow) CrossRef - Therapeutic Targeting of Exportin-1 in Childhood Cancer
Basia Galinski et al, 2021, Cancers CrossRef - Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway
Wen Yu Shao et al, 2017, Cancer Biology & Therapy CrossRef - Structural Basis of Targeting the Exportin CRM1 in Cancer
Achim Dickmanns et al, 2015, Cells CrossRef - XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
null Birnbaum et al, 2019, Journal of Clinical Medicine CrossRef